US Rheumatoid Arthritis Drug Market, Dosage, Price, Sales Insight 2021 - 2026 .
Report Highlights:
Comprehensive Insight On Approved Rheumatoid Arthritis Drugs Price & Dosage Analysis For US Market
Rheumatoid Arthritis Drugs Patent Timeline
Dosage, Formulation, Patent, Pricing Insight by Drug Class
300 Page Data & Analysis On All Approved Drugs In Market
Download Report:
In US, rheumatoid arthritis is emerging as one of the most commonly diagnosed autoimmune disease and its prevalence rate is increasing at an alarming rate. Rheumatoid arthritis is a type of autoimmune arthritis, which has an incidence rate of about 41 per 100,000 populations of US. About 130,000 newly diagnosed cases of rheumatoid arthritis is observed every year in US and about 1.5 Million people are living with rheumatoid arthritis in US during year 2020. Further, it is observed that women are three times more likely than men to develop rheumatoid arthritis as compared to males. Therefore, about 75% of